{
  "actions": [
    {
      "acted_at": "2016-06-08", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr5414-114", 
  "bill_type": "hr", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }
  ], 
  "congress": "114", 
  "cosponsors": [
    {
      "district": "6", 
      "name": "Pallone, Frank, Jr.", 
      "sponsored_at": "2016-06-08", 
      "state": "NJ", 
      "thomas_id": "00887", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2016-06-08", 
  "number": "5414", 
  "official_title": "To amend the Federal Food, Drug, and Cosmetic Act to provide for establishment of one or more Intercenter Institutes within the Food and Drug Administration for a major disease area or areas, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "s2700-114", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "FDA Cross-Center Collaboration Act of 2016", 
  "sponsor": {
    "district": "6", 
    "name": "Upton, Fred", 
    "state": "MI", 
    "thomas_id": "01177", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2016-06-08", 
  "subjects": [
    "Health"
  ], 
  "subjects_top_term": "Health", 
  "summary": null, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "FDA Cross-Center Collaboration Act of 2016", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend the Federal Food, Drug, and Cosmetic Act to provide for establishment of one or more Intercenter Institutes within the Food and Drug Administration for a major disease area or areas, and for other purposes.", 
      "type": "official"
    }
  ], 
  "updated_at": "2016-06-25T07:08:58-04:00", 
  "url": "http://thomas.loc.gov/cgi-bin/bdquery/z?d114:HR5414:@@@L&summ2=m&"
}